SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Andersen Peter M) "

Sökning: WFRF:(Andersen Peter M)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
321.
  • Zetterström, Per, et al. (författare)
  • Composition of soluble misfolded superoxide Dismutase-1 in murine models of Amyotrophic Lateral Sclerosis
  • 2013
  • Ingår i: Neuromolecular medicine. - 1535-1084 .- 1559-1174. ; 15:1, s. 147-158
  • Tidskriftsartikel (refereegranskat)abstract
    • A common cause of amyotrophic lateral sclerosis is mutations in superoxide dismutase-1, which provoke the disease by an unknown mechanism. We have previously found that soluble hydrophobic misfolded mutant human superoxide dismutase-1 species are enriched in the vulnerable spinal cords of transgenic model mice. The levels were broadly inversely correlated with life spans, suggesting involvement in the pathogenesis. Here, we used methods based on antihuman superoxide dismutase-1 peptide antibodies specific for misfolded species to explore the composition and amounts of soluble misfolded human superoxide dismutase-1 in tissue extracts. Mice expressing 5 different human superoxide dismutase-1 variants with widely variable structural characteristics were examined. The levels were generally higher in spinal cords than in other tissues. The major portion of misfolded superoxide dismutase-1 was shown to be monomers lacking the C57-C146 disulfide bond with large hydrodynamic volume, indicating a severely disordered structure. The remainder of the misfolded protein appeared to be non-covalently associated in 130- and 250-kDa complexes. The malleable monomers should be prone to aggregate and associate with other cellular components, and should be easily translocated between compartments. They may be the primary cause of toxicity in superoxide dismutase-1-induced amyotrophic lateral sclerosis.
  •  
322.
  • Zetterström, Per, 1980-, et al. (författare)
  • Misfolded superoxide dismutase-1 in CSF from amyotrophic lateral sclerosis patients
  • 2011
  • Ingår i: Journal of Neurochemistry. - 0022-3042 .- 1471-4159. ; 117:1, s. 91-99
  • Tidskriftsartikel (refereegranskat)abstract
    • Several of the superoxide dismutase-1 (SOD1) mutations linked to amyotrophic lateral sclerosis (ALS) lead to synthesis of structurally defective molecules, suggesting that any cytotoxic conformational species common for all mutations should be misfolded. SOD1 can be secreted and evidence from ALS model systems suggests that extracellular SOD1 may be involved in cytotoxicity. Three ELISAs specifically reacting with different sequence segments in misfolded SOD1 species were used for analysis of CSF from 38 neurological controls and from 96 ALS patients, 57 of whom were sporadic cases and 39 familial, including 22 patients carrying SOD1 mutations. Misfolded SOD1 was found in all samples. There were, however, no significant differences between patients with and without mutations, and between all the ALS patients and the controls. The estimated concentration of misfolded SOD1 in the interstitium of the CNS is a 1000 times lower than that required for appreciable cytotoxicity in model systems. The results argue against a direct cytotoxic role of extracellular misfolded SOD1 in ALS. Misfolded SOD1 in CSF cannot be used as a biomarker of ALS in patients with and without mutations in the enzyme.
  •  
323.
  • Zetterström, Per, 1980-, et al. (författare)
  • Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic ALS model mice
  • 2011
  • Ingår i: Journal of Biological Chemistry. - : American Society for Biochemistry and Molecular Biology. - 0021-9258 .- 1083-351X. - 1083-351X (Electronic) 0021-9258 (Linking) ; 286:23, s. 20130-20136
  • Tidskriftsartikel (refereegranskat)abstract
    • Mutant superoxide dismutase-1 (SOD1) has an unidentified toxic property that provokes ALS. Several ALS-linked SOD1 mutations cause long C-terminal truncations, which suggests that common cytotoxic SOD1 conformational species should be misfolded and that the C-terminal end cannot be involved. The cytotoxicity may arise from interaction of cellular proteins with misfolded SOD1 species. Here we specifically immunocaptured misfolded SOD1 by the C-terminal end, from extracts of spinal cords from transgenic ALS model mice. Associated proteins were identified with proteomic techniques. Two transgenic models expressing SOD1s with contrasting molecular properties were examined: the stable G93A mutant, which is abundant in the spinal cord with only a tiny subfraction misfolded, and the scarce disordered truncation mutant G127insTGGG. For comparison, proteins in spinal cord extracts with affinity for immobilized apo G93A mutant SOD1 were determined. Two-dimensional gel patterns with a limited number of bound proteins were found, which were similar for the two SOD1 mutants. Apart from neurofilament light, the proteins identified were all chaperones and by far most abundant was Hsc70. The immobilized apo G93A SOD1, which would populate a variety of conformations, was found to bind to a considerable number of additional proteins. A substantial proportion of the misfolded SOD1 in the spinal cord extracts appeared to be chaperone-associated. Still, only about 1% of the Hsc70 appeared to be associated with misfolded SOD1. The results argue against the notion that chaperone depletion is involved in ALS pathogenesis in the transgenic models and in humans carrying SOD1 mutations.
  •  
324.
  • Zetterström, Per, 1980-, et al. (författare)
  • Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models
  • 2007
  • Ingår i: Proceedings of the National Academy of Sciences of the United States of America. - 0027-8424 .- 1091-6490. ; 104:35, s. 14157-14162
  • Tidskriftsartikel (refereegranskat)abstract
    • Mutants of superoxide dismutase-1 (SOD1) cause ALS by an unidentified cytotoxic mechanism. We have previously shown that the stable SOD1 mutants D90A and G93A are abundant and show the highest levels in liver and kidney in transgenic murine ALS models, whereas the unstable G85R and G127X mutants are scarce but enriched in the CNS. These data indicated that minute amounts of misfolded SOD1 enriched in the motor areas might exert the ALS-causing cytotoxicity. A hydrophobic interaction chromatography (HIC) protocol was developed with the aim to determine the abundance of soluble misfolded SOD1 in tissues in vivo. Most G85R and G127X mutant SOD1s bound in the assay, but only minute subfractions of the D90A and G93A mutants. The absolute levels of HIC-binding SOD1 were, however, similar and broadly inversely related to lifespans in the models. They were generally enriched in the susceptible spinal cord. The HIC-binding SOD1 was composed of disulfide-reduced subunits lacking metal ions and also subunits that apparently carried nonnative intrasubunit disulfide bonds. The levels were high from birth until death and were comparable to the amounts of SOD1 that become sequestered in aggregates in the terminal stage. The HIC-binding SOD1 species ranged from monomeric to trimeric in size. These species form a least common denominator amongst SOD1 mutants with widely different molecular characteristics and might be involved in the cytotoxicity that causes ALS.
  •  
325.
  •  
326.
  • Zhu, Shaochun, et al. (författare)
  • Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS
  • 2019
  • Ingår i: Journal of Molecular Neuroscience. - : Springer. - 0895-8696 .- 1559-1166. ; 69:4, s. 643-657
  • Tidskriftsartikel (refereegranskat)abstract
    • The neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) share some common molecular deficits including disruption of protein homeostasis leading to disease-specific protein aggregation. While insoluble protein aggregates are the defining pathological confirmation of diagnosis, patient stratification based on early molecular etiologies may identify distinct subgroups within a clinical diagnosis that would respond differently in therapeutic development programs. We are developing targeted multiple reaction monitoring (MRM) mass spectrometry methods to rigorously quantify CSF proteins from known disease genes involved in lysosomal, ubiquitin-proteasomal, and autophagy pathways. Analysis of CSF from 21 PD, 21 ALS, and 25 control patients, rigorously matched for gender, age, and age of sample, revealed significant changes in peptide levels between PD, ALS, and control. In patients with PD, levels of two peptides for chromogranin B (CHGB, secretogranin 1) were significantly reduced. In CSF of patients with ALS, levels of two peptides from ubiquitin carboxy-terminal hydrolase like protein 1 (UCHL1) and one peptide each for glycoprotein non-metastatic melanoma protein B (GPNMB) and cathepsin D (CTSD) were all increased. Analysis of patients with ALS separated into two groups based on length of survival after CSF sampling revealed that the increases in GPNMB and UCHL1 were specific for short-lived ALS patients. While analysis of additional cohorts is required to validate these candidate biomarkers, this study suggests methods for stratification of ALS patients for clinical trials and identifies targets for drug efficacy measurements during therapeutic development.
  •  
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (297)
annan publikation (12)
forskningsöversikt (7)
doktorsavhandling (5)
konferensbidrag (3)
bokkapitel (2)
visa fler...
visa färre...
Typ av innehåll
refereegranskat (280)
övrigt vetenskapligt (44)
populärvet., debatt m.m. (2)
Författare/redaktör
Andersen, Peter M. (175)
Ludolph, Albert C (51)
Marklund, Stefan L. (48)
Andersen, Peter M., ... (44)
Brännström, Thomas (39)
Weishaupt, Jochen H. (33)
visa fler...
van den Berg, Leonar ... (31)
Al-Chalabi, Ammar (30)
Robberecht, Wim (29)
Birve, Anna (27)
Veldink, Jan H. (26)
Weber, Markus (25)
Andersen, PM (23)
Van Damme, Philip (22)
Hardiman, Orla (22)
de Carvalho, Mamede (21)
Landers, John E. (21)
Silani, Vincenzo (20)
Shaw, Christopher E. (20)
Volk, Alexander E. (18)
Graffmo, Karin S (17)
Forsberg, Karin (16)
Meyer, Thomas (15)
Morrison, Karen E. (15)
Jonsson, P Andreas (15)
Shatunov, Aleksey (14)
van Rheenen, Wouter (14)
Petri, Susanne (14)
Weydt, Patrick (14)
Jonas, Jost B. (13)
Khang, Young-Ho (13)
Farzadfar, F (12)
Jonas, JB (12)
Khader, YS (12)
Khang, YH (12)
Nagel, G (12)
Hofman, Albert (12)
Farzadfar, Farshad (12)
Kasaeian, Amir (12)
Khader, Yousef Saleh (12)
Nagel, Gabriele (12)
Qorbani, Mostafa (12)
Qorbani, M (12)
Kasaeian, A (12)
Alkerwi, Ala'a (12)
Alkerwi, A (12)
Chio, Adriano (12)
Meitinger, Thomas (12)
Andersen, Peter (12)
Zetterström, Per (12)
visa färre...
Lärosäte
Umeå universitet (243)
Karolinska Institutet (49)
Lunds universitet (32)
Uppsala universitet (29)
Göteborgs universitet (19)
Stockholms universitet (17)
visa fler...
Örebro universitet (11)
Linköpings universitet (10)
Sveriges Lantbruksuniversitet (5)
Högskolan Dalarna (5)
Kungliga Tekniska Högskolan (2)
Luleå tekniska universitet (1)
Södertörns högskola (1)
Chalmers tekniska högskola (1)
Naturhistoriska riksmuseet (1)
visa färre...
Språk
Engelska (319)
Svenska (5)
Odefinierat språk (2)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (251)
Naturvetenskap (29)
Lantbruksvetenskap (3)
Teknik (2)
Samhällsvetenskap (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy